Sparsentan (PS-433540,RE-021,DARA)
CAS: 254740-64-2
Ref. 3D-EKA74064
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Name:
Sparsentan (PS-433540,RE-021,DARA)
Description:
Sparsentan is an investigational drug that acts as a selective, orally available, small-molecule inhibitor of the enzyme TGR5. It has been shown to have efficacy in animal models for metabolic disorders and infectious diseases such as atherosclerotic cardiovascular disease, cerebrotendinous xanthomatosis, monoclonal antibody-associated glomerulonephritis, diabetic neuropathy, and ldl-c lowering. Sparsentan is currently undergoing phase 2 clinical trials for type II diabetes mellitus.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
592.75 g/mol
Formula:
C32H40N4O5S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
